The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 5 01 ACQUISITION CORP | COM CL A | 33836P105 | 3,615 | 365,126 | SH | SOLE | 365,126 | 0 | 0 | ||
| AKOUOS INC | COM | 00973J101 | 19,397 | 4,135,784 | SH | SOLE | 4,135,784 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | 16,836 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| AVIDITY BIOSCIENCES INC | COM | 05370A108 | 5,675 | 390,555 | SH | SOLE | 390,555 | 0 | 0 | ||
| CABALETTA BIO INC | COM | 12674W109 | 2,188 | 2,064,263 | SH | SOLE | 2,064,263 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 554 | 1,134,511 | SH | SOLE | 1,134,511 | 0 | 0 | ||
| CINCOR PHARMA INC | COM | 17240Y109 | 81,721 | 4,337,646 | SH | SOLE | 4,337,646 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 10,185 | 1,129,200 | SH | SOLE | 1,129,200 | 0 | 0 | ||
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 16,082 | 862,286 | SH | SOLE | 862,286 | 0 | 0 | ||
| ENTRADA THERAPEUTICS INC | COM | 29384C108 | 53,694 | 4,408,379 | SH | SOLE | 4,408,379 | 0 | 0 | ||
| HOMOLOGY MEDICINES INC | COM | 438083107 | 8,936 | 4,535,919 | SH | SOLE | 4,535,919 | 0 | 0 | ||
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | 19,293 | 1,398,066 | SH | SOLE | 1,398,066 | 0 | 0 | ||
| IMPEL NEUROPHARMA INC | COM | 45258K109 | 26,886 | 2,884,791 | SH | SOLE | 2,884,791 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 9,888 | 1,027,874 | SH | SOLE | 1,027,874 | 0 | 0 | ||
| JANUX THERAPEUTICS INC | COM | 47103J105 | 5,449 | 446,266 | SH | SOLE | 446,266 | 0 | 0 | ||
| PEAR THERAPEUTICS INC | CLASS A COM | 704723105 | 28,693 | 18,631,771 | SH | SOLE | 18,631,771 | 0 | 0 | ||
| PHARVARIS N V | COM | N69605108 | 12,986 | 587,600 | SH | SOLE | 587,600 | 0 | 0 | ||
| PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 5,148 | 182,370 | SH | SOLE | 182,370 | 0 | 0 | ||
| RALLYBIO CORP | COM | 75120L100 | 28,167 | 3,730,724 | SH | SOLE | 3,730,724 | 0 | 0 | ||
| SCPHARMACEUTICALS INC | COM | 810648105 | 17,166 | 3,561,474 | SH | SOLE | 3,561,474 | 0 | 0 | ||
| VOR BIOPHARMA INC | COM | 929033108 | 31,618 | 6,361,723 | SH | SOLE | 6,361,723 | 0 | 0 | ||